CompletedNCT00713479
Varenicline safety in people with methamphetamine dependence
About this title
Read the official source — NCT00713479Medication studyAges 18–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateJuly 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00713479
- Official title
Show the full official title
A Human Laboratory Assessment of the Safety and Potential Efficacy of Varenicline in Methamphetamine-dependent Volunteers Receiving Methamphetamine
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLos Angeles
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Varenicline, then placebo and Placebo, then varenicline.
Who was this study for?
Listed age limits: 18 years to 55 years.
